|
|
Total
(n=1,240) |
Prevalence of Lipoatrophy
|
| Overall
(n=1240) |
Men
(n=628) |
Women
(n=612) |
| Gender |
|
|
|
|
| Men |
628 (50.6) |
338 (53.8) |
- |
- |
| Women |
612 (49.4) |
322 (52.6) |
- |
- |
| P value |
|
0.7 |
|
|
| Age (years) |
|
|
|
|
| 18-34 |
471 (38.0) |
240 (51.0) |
98 (40.8) |
142 (59.2) |
| 35-49 |
591 (47.7) |
329 (55.7) |
191 (58.0) |
138 (42.0) |
| 50-78 |
178 (14.3) |
91 (51.1) |
49 (53.8) |
42 (46.2) |
| P value |
|
0.3 |
0.2 |
0.4 |
| Skin color |
|
|
|
|
| White |
692 (55.8) |
329 (47.5) |
178 (54.1) |
151 (45.9) |
| Non-white |
548 (44.2) |
331 (60.4) |
160 (48.3) |
171 (51.7) |
| P value |
|
<0.001 |
<0.001 |
0.033 |
| Years at school |
|
|
|
|
| <12 |
1,097 (88.5) |
606 (55.2) |
305 (50.3) |
301 (49.7) |
| ≥ 12 |
143 (11.5) |
54 (37.8) |
33 (61.1) |
21 (38.9) |
| P value |
|
<0.001 |
<0.001 |
0.3 |
| Smoking (pack-years) |
|
|
|
|
| Never-smoker |
422 (34.0) |
202 (47.9) |
86 (42.6) |
116 (57.4) |
| <20 |
498 (40.2) |
265 (53.2) |
128 (48.3) |
137 (51.7) |
| ≥ 20 |
320 (25.8) |
193 (60.3) |
124 (64.2) |
69 (35.8) |
| P value |
|
0.003 |
0.04 |
0.10 |
| Physical activity |
|
|
|
|
| Active |
716 (57.7) |
397 (55.4) |
188 (47.4) |
209 (52.6) |
| Inactive or sedentary |
524 (42.3) |
263 (50.2) |
150 (57.0) |
113 (43.0) |
| P value |
|
0.07 |
0.3 |
0.09 |
| Binge drinking (n=1,226) |
| Yes |
211 (17.0) |
101 (47.9) |
71 (70.3) |
30 (29.7) |
| No |
1,029 (83.0) |
559 (54.3) |
267 (47.8) |
292 (52.2) |
| P value |
|
0.4 |
0.2 |
0.17 |
| Body mass index (kg/m2) |
| <25 |
708 (57.1) |
445 (62.9) |
252 (56.6) |
193 (43.4) |
| 25–29.9 |
380 (30.6) |
152 (40.0) |
74 (48.7) |
78 (51.3) |
| ≥ 30 |
152 (12.3) |
63 (41.4) |
12 (19.0) |
51 (81.0) |
| P value |
|
<0.001 |
<0.001 |
0.003 |
| Years since HIV diagnosis |
| <3 |
485 (39.1) |
234 (48.2) |
113 (48.3) |
121 (51.7) |
| 3-5 |
350 (28.3) |
174 (49.7) |
88 (50.6) |
86 (49.4) |
| ≥ 6 |
404 (32.6) |
252 (62.4) |
137 (54.4) |
115 (45.6) |
| P value |
|
<0.001 |
0.002 |
0.02 |
| Currently on HAART |
|
|
|
|
| Yes |
815 (65.7) |
474 (58.2) |
248 (52.3) |
226 (47.7) |
| No |
425 (34.3) |
186 (43.8) |
90 (48.4) |
96 (51.6) |
| P value |
|
<0.001 |
<0.001 |
0.002 |
| CD4 count (cel/mm3) (n=1,227) |
| <350 |
476 (38.8) |
265 (55.7) |
148 (55.8) |
117 (44.2) |
| ≥ 350 |
751 (61.2) |
387 (51.5) |
185 (47.8) |
202 (52.2) |
| P value |
|
0.16 |
0.04 |
0.9 |
| HIV-RNA viral load (n=1,221) |
| Undetectable |
713 (58.4) |
279 (39.1) |
151 (54.1) |
128 (45.9) |
| Detectable |
508 (41.6) |
369 (72.6) |
181 (49.1) |
188 (50.9) |
| P value |
|
0.3 |
0.3 |
0.7 |
| Total cholesterol (mg/dL) (n=1,226) |
| <200 |
854 (69.7) |
465 (54.4) |
242 (52.0) |
223 (48.0) |
| ≥ 200 |
372 (30.3) |
186 (50.0) |
89 (47.8) |
97 (52.2) |
| P value |
|
0.04 |
0.13 |
0.15 |
| HDL (mg/dL) (n=1,226) |
| <35 |
152 (12.4) |
81 (53.3) |
58 (71.6) |
23 (28.4) |
| ≥ 35 |
1,074 (87.6) (86.7) |
570 (53.1) |
273 (47.9) |
297 (52.1) |
| P value |
|
0.9 |
0.7 |
0.6 |
| LDL (mg/dL) (n=1,225) |
| <130 |
966 (78.9) |
528 (54.7) |
280 (53.0) |
248 (47.0) |
| ≥ 130 |
259 (21.1) |
122 (47.1) |
50 (41.0) |
72 (59.0) |
| P value |
|
0.03 |
0.19 |
0.09 |
| Triglycerides (mg/dL) (n=1,227) |
| <150 |
787 (64.1) |
419 (53.2) |
203 (48.4) |
216 (51.6) |
| ≥150 |
440 (35.9) |
232 (52.7) |
128 (55.2) |
104 (44.8) |
| P value |
|
0.9 |
0.10 |
0.15 |
| Fasting glucose (mg/dL) (n=1,226) |
| <126 |
1,185 (96.7) |
629 (53.1) |
316 (50.2) |
313 (49.8) |
| ≥126 |
41 (3.3) |
22 (53.7) |
15 (68.2) |
7 (31.8) |
| P value |
|
0.9 |
0.5 |
0.5 |
Percentages for the column of total add 100%; while for prevalence rates, the
100% is in the lines
|
